Facilities

How RNA is making waves in the industry – and leading to new research projects and increased demand for new manufacturing capacities.

Part 2 of our roundtable discussion with CDMOs covers outsourcing preferences, the demand for mRNA, and more.

The efforts of CDMOs have been absolutely crucial in the pandemic response. We ask five CDMO gurus how they reacted to COVID-19.

What lessons were learned from Operation Warp Speed?

Swiss firm Lonza is taking its investment in China to the next level with a manufacturing upgrade to its key site in Guangdong Province.

What are the challenges and best practices in quality control for difficult-to-inspect products?

Experts from Colorcon explain how the company’s investments in facilities and new technologies are helping the pharma sector reach its goals.

How adding barcodes to glass containers can improve traceability.

Technology transfer is full of risks. But risks can be mitigated with the right strategy.

Let’s reduce the impact of pharmaceutical effluent on the environment.